Failure of naloxone to reduce self-injurious behavior in two developmentally disabled females.

Three doses of Naloxone (0.1, 0.2 and 0.4 mg.) were compared to treatment with saline in a double-blind crossover design. Neither of the two female subjects altered their rate of self-injurious behavior as a result of treatment. The present results suggest that naloxone does not reduce self-injurious behavior in all individuals.

The dexamethasone suppression test in depressed retarded adults: preliminary findings.

This study was undertaken to determine the utility of the Dexamethasone Suppression Test (DST) for diagnosing depression in institutionalized mentally retarded persons. Depressed and nondepressed institutionalized mentally retarded persons were given 1 mg dexamethasone for an overnight DST. Serum cortisol concentrations greater than 4 micrograms/dl at both 8:00 AM and 4:00 PM provided discrimination of depressed from nondepressed groups. Also, using the criteria of serum cortisol concentrations greater than 4 micrograms/dl at 8:00 AM and 4:00 PM, at 4:00 PM and 10:00 PM, or at 8:00 AM, 4:00 PM, and 10:00 PM differentiated these groups. These results suggest that the DST may be useful for detecting melancholia among institutionalized retarded persons.

Vasopressin analog influences the performance of males on a reaction time task.

The effects of desmopressin acetate (DDAVP), a vasopressin analogue, were investigated using the Sternberg Item Recognition Task. This task requires a subject to memorize a target set of up to four digits and then quickly to decide whether or not a given probe was in the original memory set. Fifteen college aged males were used as subjects in this study. Subjects received, in a double blind procedure, 0.6 ml of DDAVP (60 micrograms) or an equal volume of vehicle solution during the first test session. One week later, during the second test session, the hormone-placebo treatments were reversed. The results indicated significant main effects for set size and decision type and an interaction between treatment and session. Treatment with DDAVP during the second but not the first session improved performance at each set size as compared to treatment with the vehicle. These results indicate that DDAVP, combined with experience on this task, improved attentional processes but did not influence memory, which would have been indicated by an interaction between treatment and size of memory set.

Effects of desmopressin acetate (DDAVP) on the learning of a brightness discrimination.

Sixty male albino rats received DDAVP, a placebo, or control treatment and were tested on a brightness discrimination task. Three groups (DDAVP, placebo, and control) were tested in the morning and three groups were tested in the evening. The acquisition and reversal of the brightness discrimination, along with the retention of the reversal problem after a 5-day retention interval were analyzed. Inspection of forward and backward learning curves plotted for each task revealed facilitated acquisition along with an initial impairment of reversal learning in those animals treated with DDAVP. These results support a memorial interpretation of DDAVP's effects. This was short-term in duration, as no retention effects were obtained. It was also found that DDAVP's effects were not influenced by diurnal processes.